DAWN
Day One Biopharmaceuticals, Inc.·Healthcare
21.53
0.000%(+0.00)
Close PriceLast Updated: — ET
52W L: $5.6352W H: $21.53
DAWN NEWS
prnewswire.com
Apr 23
Servier completes the acquisition of Day One Biopharmaceuticals
Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S . in pediatric low-grade glioma.
prnewswire.com
Apr 9
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
defenseworld.net
Apr 7
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN - Get Free Report)'s share price reached a new 52-week high during trading on Tuesday. The company traded as high as $21.47 and last traded at $21.46, with a volume of 904610 shares traded. The stock had previously closed at $21.45. Analysts Set New Price Targets A number of
businesswire.com
Mar 26
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.
247wallst.com
Mar 11
Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn't see the snapback rally that was the star of the show Monday, at least all four major indices held their own as the conflict in Iran grinds on. The Nasdaq was able to eke out... Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More.
defenseworld.net
Mar 11
Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen
Day One Biopharmaceuticals (NASDAQ: DAWN) executives highlighted accelerating commercial momentum for OJEMDA and outlined multiple upcoming clinical catalysts during a fireside chat at TD Cowen's 46th Annual Healthcare Conference. Charles York, the company's CFO and COO, said 2025 marked a "fantastic year" for Day One as it delivered its first full year of OJEMDA sales following
